Steve O'Loughlin
Director of Finance/CFO chez ACTINIUM PHARMACEUTICALS, INC.
Fortune : 9 263 $ au 31/03/2024
Profil
Steve O'Loughlin is currently the Chief Financial & Accounting Officer at Actinium Pharmaceuticals, Inc. Prior to this, he was the Vice President-Corporate Finance & Development at Protea Biosciences Group, Inc. from 2012 to 2015.
He completed his undergraduate degree at Ramapo College of New Jersey.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/12/2023 | 1 183 ( 0,00% ) | 9 263 $ | 31/03/2024 |
Postes actifs de Steve O'Loughlin
| Sociétés | Poste | Début |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Director of Finance/CFO | 15/05/2017 |
Anciens postes connus de Steve O'Loughlin
| Sociétés | Poste | Fin |
|---|---|---|
| PROTEA BIOSCIENCES GROUP, INC | Corporate Officer/Principal | 01/06/2015 |
Formation de Steve O'Loughlin
| Ramapo College of New Jersey | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Protea Biosciences Group, Inc.
 Protea Biosciences Group, Inc. Miscellaneous Commercial ServicesCommercial Services Protea Biosciences Group, Inc. engaged in the provision of molecular information services. It offers direct analysis, mapping, and display of biologically active molecules in living cells and tissue samples through its platform technology. The company was founded by Stephen C. Turner in July 2001 and was headquartered in Morgantown, WV. | Commercial Services |
